Share
Market Research Report

PATIENT DERIVED XENOGRAFT MODEL MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2026-2033)

Segmentation
  • By Model TypeCell line derived models · Patient derived organoids · Genetically engineered models and Others (Primary cell derived models, cell processed models etc.)
  • By Implantation MethodSubcutaneous Implantation · Orthopedic Implantation and Others
  • By Tumor TypeBlood Cancer Models · Solid Tumor Models · Pediatric Tumor Models · Other Rare Tumor Models · Combination PDX Models · Custom PDX Models · Others
  • By ApplicationGastrointestinal Tumor Model · Gynecological Tumor Model · Respiratory Tumor Model and Other Tumor Model
  • By End UserPharmaceutical & Biotechnology Companies · Contract Research Organizations (CROs) · Academic & Research Institutions · Others
  • By GeographyNorth America · Latin America · Europe · Asia Pacific · Middle East & Africa
  • Published In27 Apr 2026
  • Report CodeCMI6506
  • Pages250+
  • FormatsExcel and PDF
  • Base Year2025
  • Estimated Year2026
  • Historical Range2020 - 2024
  • Forecast Period2026-2033
  1. Research Objectives and Assumptions

    • Research Objectives
    • Assumptions
    • Abbreviations
  2. Market Purview

    • Report Description
      • Market Definition and Scope
    • Executive Summary
      • Market Patient Derived Xenograft Model, By Model Type
      • Market Patient Derived Xenograft Model, By Implantation Method
      • Market Patient Derived Xenograft Model, By Tumor Type
      • Market Patient Derived Xenograft Model, By End User
      • Market Patient Derived Xenograft Model, By Region
    • Coherent Opportunity Map (COM)
  3. Market Dynamics, Regulations, and Trends Analysis

    • Market Dynamics
      • Drivers
        • Increasing Cancer Research
      • Restraints
        • Limitations of PDX Models
      • Opportunities
        • Applications in Immunotherapy Testing
    • Impact Analysis 
    • Key Highlights
    • Regulatory Scenario
    • Product launch/Approvals
    • PEST Analysis
    • PORTER’s Analysis
    • Merger and Acquisition Scenario
  4. Patient Derived Xenograft Model Market , By Model Type, 2021 - 2033, (US$ Mn)

    • Introduction
      • Market Share Analysis, 2026 and 2033 (%)
      • Y-o-Y Growth Analysis, 2022 – 2033
      • Segment Trends
    • Tumor explant models
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Mn)
    • Cell line derived models
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Mn)
    • Patient derived organoids
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Mn)
    • Genetically engineered models
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Mn)
    • Others (Primary cell derived models, cell processed models etc.)
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Mn)
  5. Patient Derived Xenograft Model Market , By Model Type, 2021 - 2033, (US$ Mn)

    • Introduction
      • Market Share Analysis, 2026 and 2033 (%)
      • Y-o-Y Growth Analysis, 2022 – 2033
      • Segment Trends
    • Subcutaneous Implantation
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Mn)
    • Orthopedic Implantation
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Mn)
    • Others
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Mn)
  6. Patient Derived Xenograft Model Market , By Tumor Type, 2021 - 2033, (US$ Mn)

    • Introduction
      • Market Share Analysis, 2023and 2033 (%)
      • Y-o-Y Growth Analysis, 2022– 2033
    • Gastrointestinal Tumor Model
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Million)
    • Gynecological Tumor Model
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Million)
    • Respiratory Tumor Model
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Million)
    • Other Tumor Model
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Million)
  7. Patient Derived Xenograft Model Market , By End User, 2021 - 2033, (US$ Mn)

    • Introduction
      • Market Share Analysis, 2023and 2033 (%)
      • Y-o-Y Growth Analysis, 2022– 2033
      • Segment Trends
    • Pharmaceutical & Biotechnology Companies
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Million)
    • Contract Research Organizations
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Million)
    • Academic & Research Institutions
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Million)
    • Others
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Million)
  8. Patient Derived Xenograft Model Market , By

    Region, 2021 - 2033, (US$ Mn)

    • Introduction
      • Market Share Analysis, By Country, 2023and 2033 (%)
      • Y-o-Y Growth Analysis, For Country 2022–2033
      • Country Trends
    • North America
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Model Type, 2021 - 2033,(US$ Mn)
      • Market Size and Forecast, and Y-o-Y Growth, By Implantation Method, 2021 - 2033,(US$ Mn)
      • Market Size and Forecast, and Y-o-Y Growth, By Tumor Type, 2021 - 2033,(US$ Mn)
      • Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033,(US$ Mn)
      • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033,(US$ Mn)
        • U.S.
        • Canada
    • Europe
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Model Type, 2021 - 2033,(US$ Mn)
      • Market Size and Forecast, and Y-o-Y Growth, By Implantation Method, 2021 - 2033,(US$ Mn)
      • Market Size and Forecast, and Y-o-Y Growth, By Tumor Type, 2021 - 2033,(US$ Mn)
      • Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033,(US$ Mn)
      • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033,(US$ Mn)
        • Germany
        • U.K.
        • Spain
        • France
        • Italy
        • Russia
        • Rest of Europe
    • Asia Pacific
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Model Type, 2021 - 2033,(US$ Mn)
      • Market Size and Forecast, and Y-o-Y Growth, By Implantation Method, 2021 - 2033,(US$ Mn)
      • Market Size and Forecast, and Y-o-Y Growth, By Tumor Type, 2021 - 2033,(US$ Mn)
      • Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033,(US$ Mn)
      • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033,(US$ Mn)
        • China
        • India
        • Japan
        • Australia
        • South Korea
        • ASEAN
        • Rest of Asia Pacific
    • Latin America
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Model Type, 2021 - 2033,(US$ Mn)
      • Market Size and Forecast, and Y-o-Y Growth, By Implantation Method, 2021 - 2033,(US$ Mn)
      • Market Size and Forecast, and Y-o-Y Growth, By Tumor Type, 2021 - 2033,(US$ Mn)
      • Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033,(US$ Mn)
      • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033,(US$ Mn)
        • Brazil
        • Mexico
        • Argentina
        • Rest of Latin America
    • Middle East
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Model Type, 2021 - 2033,(US$ Mn)
      • Market Size and Forecast, and Y-o-Y Growth, By Implantation Method, 2021 - 2033,(US$ Mn)
      • Market Size and Forecast, and Y-o-Y Growth, By Tumor Type, 2021 - 2033,(US$ Mn)
      • Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033,(US$ Mn)
      • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033,(US$ Mn)
        • GCC
        • Israel
        • Rest of Middle East
    • Africa
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Model Type, 2021 - 2033,(US$ Mn)
      • Market Size and Forecast, and Y-o-Y Growth, By Implantation Method, 2021 - 2033,(US$ Mn)
      • Market Size and Forecast, and Y-o-Y Growth, By Tumor Type, 2021 - 2033,(US$ Mn)
      • Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033,(US$ Mn)
      • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2021 - 2033,(US$ Mn)
        • North Africa
        • Central Africa
        • South Africa
  9. Competitive Landscape

    • THE JACKSON LABORATORY
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Champions Oncology, Inc
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Strategies
    • Charles River Laboratories
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Strategies
    • Crown Bioscience
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Strategies
    • Hera Biolabs
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Strategies
    • Horizon Discovery Group
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Strategies
    • Oncodesign
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Strategies
    • Pharmatest Services
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Strategies
    • Shanghai LIDE Biotech
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Aragen Life Sciences Ltd.
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Strategies
    • Creative Animodel
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Strategies
    • Urosphere
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Strategies
    • Applied StemCell
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Strategies
    • WuXi AppTec
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Strategies
    • Analyst Views
  10. Section

    • Research Methodology
    • About us

*Browse 44 market data tables and 40 figures on “Patient Derived Xenograft Model Market” - Global forecast to 2033